Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Phosphorus binders: The new and the old, and how to choose

Arjun Sekar, MD, Taranpreet Kaur, MD, Joseph V. Nally, MD, Hernan Rincon-Choles, MD, Stacey Jolly, MD, MAS, FACP and Georges N. Nakhoul, MD
Cleveland Clinic Journal of Medicine August 2018, 85 (8) 629-638; DOI: https://doi.org/10.3949/ccjm.85a.17054
Arjun Sekar
Associates in Kidney Care, Des Moines, IA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Taranpreet Kaur
Department of Nephrology and Hypertension, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph V. Nally Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hernan Rincon-Choles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Jolly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georges N. Nakhoul
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Hormonal regulation of calcium and phosphorus. Serum calcium and phosphorus balance is maintained by a tight interplay between parathyroid hormone (PTH), vitamin D, and fibroblast growth factor 23 (FGF23).

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Pathophysiologic processes of hyperphosphatemia. As the glomerular filtration rate (GFR) drops, the serum inorganic phosphorus (Pi) level spikes and prompts a series of responses that include stepwise increases in fibroblast growth factor 23 (FGF23), decreases in calcitriol (1,25 D), and increases in parathyroid hormone (PTH).

Tables

  • Figures
    • View popup
    TABLE 1

    Daily intake and output of phosphorus

    Intake: 1,200–1,500 mg/day, mostly from protein
    Absorption: 800–900 mg (promoted by vitamin D)
    Disposition:
     Bone (as hydroxyapatite) 85%
     Soft tissue 15%
     Extracellular fluid 0.1%
    Excretion:
     Urine 650–700 mg (fractional excretion 15%–20%)
     Feces 150–200 mg
    • View popup
    TABLE 2

    Factors that affect the serum phosphorus level

    Increase phosphorusDecrease phosphorus
    Renal failure (decreases urinary excretion)
    Vitamin D (increases intestinal absorption)
    Increased phosphate load (from diet, drugs, cell lysis)
    Fibroblast growth factor 23
    (increases urinary excretion, decreases intestinal absorption, decreases parathyroid hormone)
    Dietary restriction
    Phosphate binders
    Parathyroid hormone increases phosphorus release from the bone while increasing its excretion from the kidney, so the plasma levels are minimally affected.
    • View popup
    TABLE 3

    Phosphate content of foods

    High phosphate-to-protein ratio (avoid in end-stage kidney disease)
    Egg yolk
    Beans, lentils, and dried peas
    Cheese
    Milk
    Nuts and seeds
    Organ meats and certain seafoods like shrimp, crab, and oysters
    Low phosphate-to-protein ratio
    Egg white
    White bread, pasta, crackers
    Soups that are water-based or broth-based
    Seafoods like sea bass
    • View popup
    TABLE 4

    Phosphorus binders

    Phosphorus binderDosePBED of 1 tablet to 1 g of calcium carbonateAverage number of pills to reach PBED 6 gFormulationAdvantagesDisadvantagesCost for 200 pills
    Calcium carbonate750–3,500 mg0.758Swallowed and chewable tabletsLow cost, over-the-counterCalcium burden      $5
    Calcium acetate667–6,000 mg0.679Swallowed tabletLess calcium than calcium carbonateNeeds prescription  $105
    Lanthanum500–3,750 mg1.03Chewable and swallowed tablet (can be crushed)Lower pill burden than many other bindersExpensive$2,880
    Sevelamer800–8,000 mg0.6010Swallowed tablet and granule packetsLowers low-density lipoprotein cholesterolHigh pill burden  $756
    Sucroferric oxyhydroxide500–3,000 mg1.63.75Chewable tabletLower pill burdenCost and gastrointestinal side effects$2,890
    Ferric citrate210–2,500 mg2.09Swallowed tabletImproves iron parametersExpensive$1,284
    • PBED = phosphorus binder equivalent dose

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (8)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 8
1 Aug 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phosphorus binders: The new and the old, and how to choose
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phosphorus binders: The new and the old, and how to choose
Arjun Sekar, Taranpreet Kaur, Joseph V. Nally, Hernan Rincon-Choles, Stacey Jolly, Georges N. Nakhoul
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 629-638; DOI: 10.3949/ccjm.85a.17054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phosphorus binders: The new and the old, and how to choose
Arjun Sekar, Taranpreet Kaur, Joseph V. Nally, Hernan Rincon-Choles, Stacey Jolly, Georges N. Nakhoul
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 629-638; DOI: 10.3949/ccjm.85a.17054
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • ROLE OF THE INTERNIST
    • PATHOPHYSIOLOGY OF HYPERPHOSPHATEMIA
    • HYPERPHOSPHATEMIA MAY LEAD TO VASCULAR CALCIFICATION
    • DIETARY RESTRICTION OF PHOSPHORUS
    • PHOSPHORUS AND DIALYSIS
    • PHOSPHORUS BINDERS
    • CHOOSING THE APPROPRIATE PHOSPHORUS BINDER
    • SPECIAL CIRCUMSTANCES FOR THE USE OF PHOSPHORUS BINDERS
    • FUTURE DIRECTIONS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Calcific uremic arteriolopathy
  • Phosphorus in kidney disease: Culprit or bystander?
  • PubMed
  • Google Scholar

Cited By...

  • Sucroferric Oxyhydroxide as Part of Combination Phosphate Binder Therapy among Hemodialysis Patients
  • Phosphorus in kidney disease: Culprit or bystander?
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Drug Therapy
  • Endocrinology
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire